Coles N Anthony

Coles N Anthony is listed in filings as Director at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN) and Cerevel Therapeutics Holdings, Inc. (CERE). The current snapshot covers public activity from Jul 3, 2024 to Jan 6, 2026. Reported amounts are shown as $1.4M to $1.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.